Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Gilboa

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Med (New York, N.Y.)|August 20, 2021
Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigensVijayashree Mysore, Xavier Cullere, Matthew L Settles, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 12, 2026
Adjunctive cenobamate in children and adolescents - real-world data from a retrospective multicenter studyLeo Arkush, Rinat Komargodski, Hagar Bernad Elazari, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2024
Toward the quantification of α-synuclein aggregates with digital seed amplification assaysTal Gilboa, Zoe Swank, Rohan Thakur, et al.
American Journal of Human Genetics|June 11, 2019
Pathogenic Variants in NUP214 Cause "Plugged" Nuclear Pore Channels and Acute Febrile EncephalopathyBoris Fichtman, Tamar Harel, Nitzan Biran, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2020
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 PatientsMaia Norman, Tal Gilboa, Alana F Ogata, et al.
Clinical Chemistry|September 8, 2020
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe DiseaseAlana F Ogata, Adam M Maley, Connie Wu, et al.
The Journal of Applied Laboratory Medicine|July 1, 2021
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
European Journal of Human Genetics : EJHG|August 9, 2023
Novel homozygous variants in PRORP expand the genotypic spectrum of combined oxidative phosphorylation deficiency 54Thomas B Smith, Alessandro Rea, Huw B Thomas, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Med (New York, N.Y.)|August 20, 2021
Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigensVijayashree Mysore, Xavier Cullere, Matthew L Settles, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 12, 2026
Adjunctive cenobamate in children and adolescents - real-world data from a retrospective multicenter studyLeo Arkush, Rinat Komargodski, Hagar Bernad Elazari, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2024
Toward the quantification of α-synuclein aggregates with digital seed amplification assaysTal Gilboa, Zoe Swank, Rohan Thakur, et al.
American Journal of Human Genetics|June 11, 2019
Pathogenic Variants in NUP214 Cause "Plugged" Nuclear Pore Channels and Acute Febrile EncephalopathyBoris Fichtman, Tamar Harel, Nitzan Biran, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2020
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 PatientsMaia Norman, Tal Gilboa, Alana F Ogata, et al.
Clinical Chemistry|September 8, 2020
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe DiseaseAlana F Ogata, Adam M Maley, Connie Wu, et al.
The Journal of Applied Laboratory Medicine|July 1, 2021
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
European Journal of Human Genetics : EJHG|August 9, 2023
Novel homozygous variants in PRORP expand the genotypic spectrum of combined oxidative phosphorylation deficiency 54Thomas B Smith, Alessandro Rea, Huw B Thomas, et al.
Pageof 7